The Euro-Global Platformfor Mechanism-basedDrug Repurposing

From imprecise drug therapyto precision medicine

A new era for drug repurposing

Mechanism-based drug repurposing will revolutionize the way we approach drugs. It will help us find new uses for already registered drugs, increase precision and radically cut down on costs and time in the drug development process. Ultimately, this paradigm shift will streamline the transition to clinical trials that are fit-for-purpose, innovation-driven and compliant with the highest standards in safety and operational excellence.

New disease definitions

Our disease definitions are updated. Most underlying disease mechanisms are not understood and are thus treated symptomatically in an imprecise manner

Organ-agnostic medicine

Chronic diseases are only chronic because we do not know how to cure them yet. Our organ-agnostic approach will push drug repurposing to its full potential

Network pharmacology

Unlocking the mechanisms governing a specific disease will allow us to repurpose drugs for another disease sharing some of those common elements

Precision medicine

Breakthroughs in precision, efficacy and cost-effectiveness will help de-risk drug repurposing and pave the way towards personalized therapies

Platforming the future

We are building a unique platform for drug repurposing, pooling stakeholders and expertise globally to create a fully-fledged, made in Europe infrastructure for drug repurposing: a disruptive mix of bioinformatics, repurposing, precision diagnostics and innovative trials.

EXPLORE OUR PLATFORM